Scientific Advisory Board

Invectys’ Scientific and Clinical Board is composed of globally recognized top specialists and key opinion leaders:

Professor Maurizio Zanetti, M.D. A professor of Medicine at the UCSD, Pr. Zanetti is the pioneer of T cell responses to telomerase reverse transcriptase in cancer patients. He is the Director of the Laboratory of Immunology at the UCSD Moores Cancer Center. He brings his vast knowledge to Invectys’ strategic decisions, especially in the domain of T cells. Academic profile

Edward Ball, M.D. Edward (Ted) D. Ball, M.D.  is a tenured Professor of Medicine at the University of California San Diego.  He was among the first to develop monoclonal antibodies to cell surface antigens on human leukemia cells and to apply them in therapeutic clinical trials.  Dr. Ball was a co-founder of Medarex, which was acquired by Bristol-Myers-Squib to utilize its human checkpoint inhibiting antibodies ipilimumab and nivolumab. Dr. Ball’s experience with monoclonal antibodies will aid Invectys in the development of new therapies. Academic profile

Olivera (Olja) J. Finn, Ph.D. Dr. Finn is University of Pittsburgh Distinguished Professor of Immunology and Surgery. After receiving her Ph.D. in Medical Microbiology at Stanford University in 1980 and completing her postdoctoral training in Immuno-oncology there in 1982, Dr. Finn started her research at Duke University and in 1991 moved to the University of Pittsburgh. She gained prominence through her basic and applied research on tumor antigens and cancer vaccines. She has served and currently serves on NCI study sections and was a member of the NCI Board of Scientific Councilors. Dr. Finn is member of the American Association of Immunologists – where she served as President in 2007/2008 – the American Association for Cancer Research (AACR) and the Society for Immunotherapy of Cancer (SITC). Dr. Finn received numerous awards including the AAI Life Time Achievement Award (2016), the NCI Outstanding Investigator Award (2016), the AACR CIR Lloyd Old Cancer Immunology Prize (2017) and SITC Richard Smalley Award (2019). In 2019 she was inducted into the inaugural class of AAI Distinguished Fellows. Academic profile